The Trump administration’s proposed cuts at the National Institutes of Health and Food and Drug Administration could lower ...

For years, inspectors have uncovered dirty equipment, contaminated supplies and fraudulent testing records in some overseas factories — serious safety and quality breaches that can sicken or kill ...

An estimated 53 drugs would not enter the market in the next 30 years if the NIH is hit with a permanent 10% budget cut and the FDA experiences a nine-month drug review delay due to staffing cuts, the ...

FDA employees are spooked by increasing political involvement in regulatory decisions, frustrated by the impact of cuts to administrative staff who supported drug reviews and inspections, and fed ...

An analysis from the Congressional Budget Office warns that cuts to the National Institutes of Health and FDA drug reviews could significantly reduce the number of new medications reaching the U.S.

Thousands of health workers lost their jobs this week after a U.S. Supreme Court ruling cleared the way for the Trump ...

FDA staff reviewers recommended the shots be approved for anyone 12 and older. But the FDA memos show Prasad limited the use to seniors and certain higher-risk Americans.

Amid news reports describing the layoffs at the FDA, Kennedy did not specify how many people would be reinstated. ProPublica spoke to 10 current and former FDA staff members and leaders in recent ...

Beyond staff cuts, the departures of investigators in recent months have left less experienced people tasked with rooting out dangerous manufacturing practices.